|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
31,350,000 |
Market
Cap: |
16.03(M) |
Last
Volume: |
15,038 |
Avg
Vol: |
14,997 |
52
Week Range: |
$0.2246 - $0.648 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
9,750 |
Total Buy Value |
$0 |
$0 |
$0 |
$4,584 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
60,000 |
60,000 |
60,000 |
60,000 |
Total Sell Value |
$950,777 |
$950,777 |
$950,777 |
$950,777 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
3 |
3 |
3 |
3 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-10-25 |
4 |
S |
$24.69 |
$209,892 |
D/D |
(8,500) |
2,799 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-10-25 |
4 |
OE |
$2.93 |
$24,905 |
D/D |
8,500 |
11,299 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-10-22 |
4 |
S |
$24.60 |
$14,760 |
D/D |
(600) |
2,799 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-10-22 |
4 |
OE |
$2.93 |
$1,758 |
D/D |
600 |
3,399 |
|
- |
|
Dunton Alan W |
Director |
|
2010-08-02 |
4 |
S |
$22.30 |
$133,791 |
D/D |
(6,000) |
0 |
|
- |
|
Dunton Alan W |
Director |
|
2010-08-02 |
4 |
OE |
$5.69 |
$34,140 |
D/D |
6,000 |
6,000 |
|
- |
|
Dunton Alan W |
Director |
|
2010-07-26 |
4 |
S |
$21.12 |
$60,476 |
D/D |
(2,864) |
0 |
|
- |
|
Dunton Alan W |
Director |
|
2010-07-26 |
4 |
OE |
$5.69 |
$16,296 |
D/D |
2,864 |
2,864 |
|
- |
|
Dunton Alan W |
Director |
|
2010-07-23 |
4 |
S |
$21.00 |
$49,063 |
D/D |
(2,336) |
0 |
|
- |
|
Dunton Alan W |
Director |
|
2010-07-23 |
4 |
OE |
$5.69 |
$13,292 |
D/D |
2,336 |
2,336 |
|
- |
|
Dunton Alan W |
Director |
|
2010-07-15 |
4 |
S |
$20.72 |
$140,911 |
D/D |
(6,800) |
0 |
|
- |
|
Dunton Alan W |
Director |
|
2010-07-15 |
4 |
OE |
$5.69 |
$38,692 |
D/D |
6,800 |
6,800 |
|
- |
|
Brown Julia R |
Director |
|
2010-05-21 |
4 |
S |
$23.13 |
$169,018 |
D/D |
(7,307) |
0 |
|
- |
|
Brown Julia R |
Director |
|
2010-05-21 |
4 |
OE |
$8.70 |
$63,571 |
D/D |
7,307 |
7,307 |
|
- |
|
Brown Julia R |
Director |
|
2010-05-20 |
4 |
S |
$22.97 |
$119,278 |
D/D |
(5,193) |
0 |
|
- |
|
Brown Julia R |
Director |
|
2010-05-20 |
4 |
OE |
$8.70 |
$45,179 |
D/D |
5,193 |
5,193 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-05-18 |
4 |
S |
$24.70 |
$84,572 |
D/D |
(3,424) |
2,799 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-05-18 |
4 |
OE |
$2.93 |
$10,032 |
D/D |
3,424 |
6,223 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-05-17 |
4 |
S |
$24.21 |
$212,745 |
D/D |
(8,782) |
2,799 |
|
- |
|
Musso Alan A |
SVP, CFO & Treasurer |
|
2010-05-17 |
4 |
OE |
$2.93 |
$43,959 |
D/D |
8,782 |
3,181 |
|
- |
|
Richard John P |
Director |
|
2010-05-14 |
4 |
S |
$24.22 |
$205,863 |
D/D |
(8,500) |
5,333 |
|
- |
|
Richard John P |
Director |
|
2010-05-14 |
4 |
OE |
$0.08 |
$53,325 |
D/D |
8,500 |
13,833 |
|
- |
|
Dunbar Geoffrey C |
SVP, Clin. Dev. & Reg. Affairs |
|
2010-05-13 |
4 |
S |
$25.00 |
$37,350 |
D/D |
(1,494) |
1,153 |
|
- |
|
Dunbar Geoffrey C |
SVP, Clin. Dev. & Reg. Affairs |
|
2010-05-13 |
4 |
OE |
$1.75 |
$2,615 |
D/D |
1,494 |
2,647 |
|
- |
|
Hodges Mauri K |
VP Finance & Controller |
|
2010-05-13 |
4 |
S |
$25.00 |
$35,050 |
D/D |
(1,402) |
1,159 |
|
- |
|
530 Records found
|
|
Page 12 of 22 |
|
|